Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Income towards Parent Company: 2009-2025

Historic Income towards Parent Company for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$1.1 million.

  • Lifecore Biomedical's Income towards Parent Company fell 38333.33% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 1543.59%. This contributed to the annual value of -$38.7 million for FY2025, which is 1543.59% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical's Income towards Parent Company is -$1.1 million, which was up 92.23% from -$14.8 million recorded in Q1 2025.
  • Lifecore Biomedical's 5-year Income towards Parent Company high stood at $1.9 million for Q3 2023, and its period low was -$51.6 million during Q2 2022.
  • For the 3-year period, Lifecore Biomedical's Income towards Parent Company averaged around -$6.3 million, with its median value being -$1.7 million (2023).
  • As far as peak fluctuations go, Lifecore Biomedical's Income towards Parent Company soared by 143.58% in 2023, and later plummeted by 38,333.33% in 2025.
  • Lifecore Biomedical's Income towards Parent Company (Quarterly) stood at -$46.0 million in 2021, then spiked by 92.17% to -$3.6 million in 2022, then spiked by 99.33% to -$24,000 in 2023, then crashed by 27,279.17% to -$6.6 million in 2024, then plummeted by 38,333.33% to -$1.1 million in 2025.
  • Its Income towards Parent Company was -$1.1 million in Q2 2025, compared to -$14.8 million in Q1 2025 and -$6.6 million in Q4 2024.